HEADER TRANSFERASE 11-JUL-19 6S90
TITLE BTK IN COMPLEX WITH AN INHIBITOR
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE BTK;
COMPND 3 CHAIN: A, B;
COMPND 4 SYNONYM: AGAMMAGLOBULINEMIA TYROSINE KINASE,ATK,B-CELL PROGENITOR
COMPND 5 KINASE,BPK,BRUTON TYROSINE KINASE;
COMPND 6 EC: 2.7.10.2;
COMPND 7 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: BTK, AGMX1, ATK, BPK;
SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA;
SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM;
SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108
KEYWDS BTK, BRUTON TYROSINE KINASE, AGAMMAGLOBULINAEMIA TYROSINE KINASE,
KEYWDS 2 ATK, B-CELL PROGENITOR KINASE, TRANSFERASE
EXPDTA X-RAY DIFFRACTION
AUTHOR S.GUTMANN,A.HINNIGER
REVDAT 3 15-MAY-24 6S90 1 REMARK
REVDAT 2 30-OCT-19 6S90 1 JRNL
REVDAT 1 18-SEP-19 6S90 0
JRNL AUTH R.PULZ,D.ANGST,J.DAWSON,F.GESSIER,S.GUTMANN,R.HERSPERGER,
JRNL AUTH 2 A.HINNIGER,P.JANSER,G.KOCH,L.REVESZ,A.VULPETTI,R.WAELCHLI,
JRNL AUTH 3 A.ZIMMERLIN,B.CENNI
JRNL TITL DESIGN OF POTENT AND SELECTIVE COVALENT INHIBITORS OF
JRNL TITL 2 BRUTON'S TYROSINE KINASE TARGETING AN INACTIVE CONFORMATION.
JRNL REF ACS MED.CHEM.LETT. V. 10 1467 2019
JRNL REFN ISSN 1948-5875
JRNL PMID 31620235
JRNL DOI 10.1021/ACSMEDCHEMLETT.9B00317
REMARK 2
REMARK 2 RESOLUTION. 1.82 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : BUSTER 2.11.7
REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER,
REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN,
REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.82
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.04
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 98.3
REMARK 3 NUMBER OF REFLECTIONS : 46198
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.169
REMARK 3 R VALUE (WORKING SET) : 0.167
REMARK 3 FREE R VALUE : 0.201
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.920
REMARK 3 FREE R VALUE TEST SET COUNT : 2274
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 50
REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.82
REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.84
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 83.12
REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 924
REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2161
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 884
REMARK 3 BIN R VALUE (WORKING SET) : 0.2150
REMARK 3 BIN FREE R VALUE : 0.2383
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.33
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 40
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 4157
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 88
REMARK 3 SOLVENT ATOMS : 467
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 17.47
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 0.92500
REMARK 3 B22 (A**2) : -2.54220
REMARK 3 B33 (A**2) : 1.61710
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : -1.06480
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.190
REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.134
REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.120
REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.126
REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.117
REMARK 3
REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797
REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.946
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.922
REMARK 3
REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15
REMARK 3 TERM COUNT WEIGHT FUNCTION.
REMARK 3 BOND LENGTHS : 4354 ; 2.000 ; HARMONIC
REMARK 3 BOND ANGLES : 5900 ; 2.000 ; HARMONIC
REMARK 3 TORSION ANGLES : 1497 ; 2.000 ; SINUSOIDAL
REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL
REMARK 3 GENERAL PLANES : 794 ; 5.000 ; HARMONIC
REMARK 3 ISOTROPIC THERMAL FACTORS : 4354 ; 20.000 ; HARMONIC
REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL
REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL
REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL
REMARK 3 CHIRAL IMPROPER TORSION : 542 ; 5.000 ; SEMIHARMONIC
REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL
REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL
REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL
REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL
REMARK 3 IDEAL-DIST CONTACT TERM : 5492 ; 4.000 ; SEMIHARMONIC
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.010
REMARK 3 BOND ANGLES (DEGREES) : 0.97
REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.62
REMARK 3 OTHER TORSION ANGLES (DEGREES) : 14.69
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : 2
REMARK 3
REMARK 3 TLS GROUP : 1
REMARK 3 SELECTION: { A|* }
REMARK 3 ORIGIN FOR THE GROUP (A): 18.9116 -17.4739 1.6939
REMARK 3 T TENSOR
REMARK 3 T11: -0.0269 T22: -0.0325
REMARK 3 T33: -0.0228 T12: -0.0003
REMARK 3 T13: 0.0063 T23: -0.0016
REMARK 3 L TENSOR
REMARK 3 L11: 0.4533 L22: 0.5060
REMARK 3 L33: 1.2057 L12: 0.0774
REMARK 3 L13: 0.0563 L23: 0.0516
REMARK 3 S TENSOR
REMARK 3 S11: -0.0188 S12: 0.0103 S13: 0.0168
REMARK 3 S21: 0.0181 S22: -0.0081 S23: 0.0047
REMARK 3 S31: 0.0544 S32: -0.0286 S33: 0.0269
REMARK 3
REMARK 3 TLS GROUP : 2
REMARK 3 SELECTION: { B|* }
REMARK 3 ORIGIN FOR THE GROUP (A): 0.9685 -4.9607 44.0999
REMARK 3 T TENSOR
REMARK 3 T11: -0.0347 T22: -0.0201
REMARK 3 T33: -0.0081 T12: -0.0044
REMARK 3 T13: -0.0109 T23: 0.0090
REMARK 3 L TENSOR
REMARK 3 L11: 0.6544 L22: 0.2836
REMARK 3 L33: 0.6867 L12: -0.0503
REMARK 3 L13: -0.1976 L23: -0.0032
REMARK 3 S TENSOR
REMARK 3 S11: 0.0181 S12: 0.0024 S13: -0.0039
REMARK 3 S21: -0.0155 S22: -0.0088 S23: 0.0127
REMARK 3 S31: -0.0158 S32: -0.0377 S33: -0.0093
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 6S90 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 12-JUL-19.
REMARK 100 THE DEPOSITION ID IS D_1292103297.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 04-OCT-13
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 8.5
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : SLS
REMARK 200 BEAMLINE : X10SA
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.999900
REMARK 200 MONOCHROMATOR : SI(III) MONOCHROMATOR
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS
REMARK 200 DATA SCALING SOFTWARE : AUTOPROC
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 46201
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.820
REMARK 200 RESOLUTION RANGE LOW (A) : 64.960
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 98.4
REMARK 200 DATA REDUNDANCY : 3.600
REMARK 200 R MERGE (I) : 0.04400
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 15.3000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.82
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.83
REMARK 200 COMPLETENESS FOR SHELL (%) : 68.3
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 42.36
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.13
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM TRIS-HCL PH 8.5, 200 MM SODIUM
REMARK 280 FORMATE, 50 MM CACL2, 25% (W/V) PEGMME 5000, VAPOR DIFFUSION,
REMARK 280 HANGING DROP, TEMPERATURE 298K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,Y,-Z
REMARK 290 3555 X+1/2,Y+1/2,Z
REMARK 290 4555 -X+1/2,Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 67.91500
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 19.68000
REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 67.91500
REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 19.68000
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 GLY A 393
REMARK 465 SER A 394
REMARK 465 GLU A 657
REMARK 465 GLU A 658
REMARK 465 GLY B 393
REMARK 465 SER B 394
REMARK 465 GLU B 657
REMARK 465 GLU B 658
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 TRP A 395 CG CD1 CD2 NE1 CE2 CE3 CZ2
REMARK 470 TRP A 395 CZ3 CH2
REMARK 470 GLN A 424 CG CD OE1 NE2
REMARK 470 TYR A 425 CD1 CD2 CE1 CE2 CZ OH
REMARK 470 GLU A 441 CG CD OE1 OE2
REMARK 470 GLU A 444 CG CD OE1 OE2
REMARK 470 LYS A 447 CG CD CE NZ
REMARK 470 GLU A 455 CG CD OE1 OE2
REMARK 470 LYS A 466 CG CD CE NZ
REMARK 470 GLN A 496 CG CD OE1 NE2
REMARK 470 GLU A 550 CG CD OE1 OE2
REMARK 470 VAL A 555 CG1 CG2
REMARK 470 MET A 570 CG SD CE
REMARK 470 LYS A 573 CG CD CE NZ
REMARK 470 GLU A 599 CG CD OE1 OE2
REMARK 470 ARG A 600 CG CD NE CZ NH1 NH2
REMARK 470 GLU A 608 CG CD OE1 OE2
REMARK 470 GLN A 612 CG CD OE1 NE2
REMARK 470 LEU A 614 CG CD1 CD2
REMARK 470 LYS A 625 CG CD CE NZ
REMARK 470 GLU A 636 CG CD OE1 OE2
REMARK 470 LYS A 637 CG CD CE NZ
REMARK 470 GLU A 640 CG CD OE1 OE2
REMARK 470 MET A 655 CE
REMARK 470 ASP A 656 CG OD1 OD2
REMARK 470 GLU B 434 CG CD OE1 OE2
REMARK 470 GLU B 455 CG CD OE1 OE2
REMARK 470 GLU B 488 CG CD OE1 OE2
REMARK 470 GLN B 496 CG CD OE1 NE2
REMARK 470 LYS B 595 CG CD CE NZ
REMARK 470 GLU B 599 CG CD OE1 OE2
REMARK 470 ARG B 600 CG CD NE CZ NH1 NH2
REMARK 470 GLU B 624 CG CD OE1 OE2
REMARK 470 LYS B 625 CG CD CE NZ
REMARK 470 GLU B 636 CG CD OE1 OE2
REMARK 470 LYS B 637 CG CD CE NZ
REMARK 470 GLU B 640 CG CD OE1 OE2
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 GLN A 424 -44.83 -148.18
REMARK 500 ARG A 520 -15.84 82.17
REMARK 500 ASP A 521 49.82 -143.85
REMARK 500 ASP A 548 105.32 -179.06
REMARK 500 GLN B 424 -45.85 -146.66
REMARK 500 LYS B 466 47.23 -88.73
REMARK 500 ARG B 520 -14.11 83.12
REMARK 500 ASP B 521 49.75 -146.62
REMARK 500 ASP B 548 106.20 -179.08
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue L0Z A 701
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue L0Z B 701
DBREF 6S90 A 393 658 UNP Q06187 BTK_HUMAN 393 658
DBREF 6S90 B 393 658 UNP Q06187 BTK_HUMAN 393 658
SEQRES 1 A 266 GLY SER TRP GLU ILE ASP PRO LYS ASP LEU THR PHE LEU
SEQRES 2 A 266 LYS GLU LEU GLY THR GLY GLN PHE GLY VAL VAL LYS TYR
SEQRES 3 A 266 GLY LYS TRP ARG GLY GLN TYR ASP VAL ALA ILE LYS MET
SEQRES 4 A 266 ILE LYS GLU GLY SER MET SER GLU ASP GLU PHE ILE GLU
SEQRES 5 A 266 GLU ALA LYS VAL MET MET ASN LEU SER HIS GLU LYS LEU
SEQRES 6 A 266 VAL GLN LEU TYR GLY VAL CYS THR LYS GLN ARG PRO ILE
SEQRES 7 A 266 PHE ILE ILE THR GLU TYR MET ALA ASN GLY CYS LEU LEU
SEQRES 8 A 266 ASN TYR LEU ARG GLU MET ARG HIS ARG PHE GLN THR GLN
SEQRES 9 A 266 GLN LEU LEU GLU MET CYS LYS ASP VAL CYS GLU ALA MET
SEQRES 10 A 266 GLU TYR LEU GLU SER LYS GLN PHE LEU HIS ARG ASP LEU
SEQRES 11 A 266 ALA ALA ARG ASN CYS LEU VAL ASN ASP GLN GLY VAL VAL
SEQRES 12 A 266 LYS VAL SER ASP PHE GLY LEU SER ARG TYR VAL LEU ASP
SEQRES 13 A 266 ASP GLU TYR THR SER SER VAL GLY SER LYS PHE PRO VAL
SEQRES 14 A 266 ARG TRP SER PRO PRO GLU VAL LEU MET TYR SER LYS PHE
SEQRES 15 A 266 SER SER LYS SER ASP ILE TRP ALA PHE GLY VAL LEU MET
SEQRES 16 A 266 TRP GLU ILE TYR SER LEU GLY LYS MET PRO TYR GLU ARG
SEQRES 17 A 266 PHE THR ASN SER GLU THR ALA GLU HIS ILE ALA GLN GLY
SEQRES 18 A 266 LEU ARG LEU TYR ARG PRO HIS LEU ALA SER GLU LYS VAL
SEQRES 19 A 266 TYR THR ILE MET TYR SER CYS TRP HIS GLU LYS ALA ASP
SEQRES 20 A 266 GLU ARG PRO THR PHE LYS ILE LEU LEU SER ASN ILE LEU
SEQRES 21 A 266 ASP VAL MET ASP GLU GLU
SEQRES 1 B 266 GLY SER TRP GLU ILE ASP PRO LYS ASP LEU THR PHE LEU
SEQRES 2 B 266 LYS GLU LEU GLY THR GLY GLN PHE GLY VAL VAL LYS TYR
SEQRES 3 B 266 GLY LYS TRP ARG GLY GLN TYR ASP VAL ALA ILE LYS MET
SEQRES 4 B 266 ILE LYS GLU GLY SER MET SER GLU ASP GLU PHE ILE GLU
SEQRES 5 B 266 GLU ALA LYS VAL MET MET ASN LEU SER HIS GLU LYS LEU
SEQRES 6 B 266 VAL GLN LEU TYR GLY VAL CYS THR LYS GLN ARG PRO ILE
SEQRES 7 B 266 PHE ILE ILE THR GLU TYR MET ALA ASN GLY CYS LEU LEU
SEQRES 8 B 266 ASN TYR LEU ARG GLU MET ARG HIS ARG PHE GLN THR GLN
SEQRES 9 B 266 GLN LEU LEU GLU MET CYS LYS ASP VAL CYS GLU ALA MET
SEQRES 10 B 266 GLU TYR LEU GLU SER LYS GLN PHE LEU HIS ARG ASP LEU
SEQRES 11 B 266 ALA ALA ARG ASN CYS LEU VAL ASN ASP GLN GLY VAL VAL
SEQRES 12 B 266 LYS VAL SER ASP PHE GLY LEU SER ARG TYR VAL LEU ASP
SEQRES 13 B 266 ASP GLU TYR THR SER SER VAL GLY SER LYS PHE PRO VAL
SEQRES 14 B 266 ARG TRP SER PRO PRO GLU VAL LEU MET TYR SER LYS PHE
SEQRES 15 B 266 SER SER LYS SER ASP ILE TRP ALA PHE GLY VAL LEU MET
SEQRES 16 B 266 TRP GLU ILE TYR SER LEU GLY LYS MET PRO TYR GLU ARG
SEQRES 17 B 266 PHE THR ASN SER GLU THR ALA GLU HIS ILE ALA GLN GLY
SEQRES 18 B 266 LEU ARG LEU TYR ARG PRO HIS LEU ALA SER GLU LYS VAL
SEQRES 19 B 266 TYR THR ILE MET TYR SER CYS TRP HIS GLU LYS ALA ASP
SEQRES 20 B 266 GLU ARG PRO THR PHE LYS ILE LEU LEU SER ASN ILE LEU
SEQRES 21 B 266 ASP VAL MET ASP GLU GLU
HET L0Z A 701 44
HET L0Z B 701 44
HETNAM L0Z 4-~{TERT}-BUTYL-~{N}-[2-METHYL-3-[6-[4-(4-
HETNAM 2 L0Z METHYLPIPERAZIN-1-YL)CARBONYLPHENYL]-7~{H}-PYRROLO[2,
HETNAM 3 L0Z 3-D]PYRIMIDIN-4-YL]PHENYL]BENZAMIDE
FORMUL 3 L0Z 2(C36 H38 N6 O2)
FORMUL 5 HOH *467(H2 O)
HELIX 1 AA1 ASP A 398 LYS A 400 5 3
HELIX 2 AA2 SER A 438 ASN A 451 1 14
HELIX 3 AA3 CYS A 481 MET A 489 1 9
HELIX 4 AA4 GLN A 494 LYS A 515 1 22
HELIX 5 AA5 ALA A 523 ARG A 525 5 3
HELIX 6 AA6 GLY A 541 VAL A 546 5 6
HELIX 7 AA7 ASP A 548 SER A 553 1 6
HELIX 8 AA8 PRO A 560 SER A 564 5 5
HELIX 9 AA9 PRO A 565 SER A 572 1 8
HELIX 10 AB1 SER A 575 SER A 592 1 18
HELIX 11 AB2 THR A 602 GLN A 612 1 11
HELIX 12 AB3 SER A 623 CYS A 633 1 11
HELIX 13 AB4 LYS A 637 ARG A 641 5 5
HELIX 14 AB5 THR A 643 ASP A 656 1 14
HELIX 15 AB6 ASP B 398 LYS B 400 5 3
HELIX 16 AB7 SER B 438 ASN B 451 1 14
HELIX 17 AB8 CYS B 481 MET B 489 1 9
HELIX 18 AB9 GLN B 494 LYS B 515 1 22
HELIX 19 AC1 ALA B 523 ARG B 525 5 3
HELIX 20 AC2 GLY B 541 VAL B 546 5 6
HELIX 21 AC3 ASP B 548 SER B 553 1 6
HELIX 22 AC4 PRO B 560 SER B 564 5 5
HELIX 23 AC5 PRO B 565 SER B 572 1 8
HELIX 24 AC6 SER B 575 SER B 592 1 18
HELIX 25 AC7 THR B 602 ALA B 611 1 10
HELIX 26 AC8 SER B 623 CYS B 633 1 11
HELIX 27 AC9 LYS B 637 ARG B 641 5 5
HELIX 28 AD1 THR B 643 ASP B 656 1 14
SHEET 1 AA1 5 LEU A 402 GLY A 411 0
SHEET 2 AA1 5 GLY A 414 TRP A 421 -1 O TYR A 418 N LEU A 405
SHEET 3 AA1 5 TYR A 425 MET A 431 -1 O ILE A 429 N LYS A 417
SHEET 4 AA1 5 PHE A 471 GLU A 475 -1 O ILE A 472 N LYS A 430
SHEET 5 AA1 5 LEU A 460 CYS A 464 -1 N GLY A 462 O ILE A 473
SHEET 1 AA2 2 CYS A 527 VAL A 529 0
SHEET 2 AA2 2 VAL A 535 VAL A 537 -1 O LYS A 536 N LEU A 528
SHEET 1 AA3 5 LEU B 402 GLY B 411 0
SHEET 2 AA3 5 GLY B 414 TRP B 421 -1 O TYR B 418 N LYS B 406
SHEET 3 AA3 5 TYR B 425 MET B 431 -1 O ILE B 429 N LYS B 417
SHEET 4 AA3 5 PHE B 471 THR B 474 -1 O ILE B 472 N LYS B 430
SHEET 5 AA3 5 LEU B 460 CYS B 464 -1 N GLY B 462 O ILE B 473
SHEET 1 AA4 2 CYS B 527 VAL B 529 0
SHEET 2 AA4 2 VAL B 535 VAL B 537 -1 O LYS B 536 N LEU B 528
CISPEP 1 ARG A 468 PRO A 469 0 -3.59
CISPEP 2 ARG B 468 PRO B 469 0 -0.47
SITE 1 AC1 22 LEU A 408 PHE A 413 VAL A 416 ALA A 428
SITE 2 AC1 22 LYS A 430 GLU A 475 TYR A 476 MET A 477
SITE 3 AC1 22 ALA A 478 ASN A 479 GLY A 480 GLU A 488
SITE 4 AC1 22 ARG A 490 ASP A 521 ASN A 526 SER A 538
SITE 5 AC1 22 ASP A 539 VAL A 546 TYR A 551 HOH A 844
SITE 6 AC1 22 HOH A 904 HOH A 943
SITE 1 AC2 20 LYS B 406 PHE B 413 VAL B 416 TYR B 418
SITE 2 AC2 20 ALA B 428 LYS B 430 GLU B 475 TYR B 476
SITE 3 AC2 20 MET B 477 ALA B 478 ASN B 479 GLY B 480
SITE 4 AC2 20 ASP B 521 ASN B 526 ASP B 539 VAL B 546
SITE 5 AC2 20 TYR B 551 HOH B 888 HOH B 960 HOH B 975
CRYST1 135.830 39.360 105.190 90.00 111.18 90.00 C 1 2 1 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.007362 0.000000 0.002853 0.00000
SCALE2 0.000000 0.025407 0.000000 0.00000
SCALE3 0.000000 0.000000 0.010195 0.00000